Gene · 132
Papers2,830
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
321 to 340 of 2,830
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Emerging Role of Nicotinamide Riboside in Health and Diseases. | Nutrients | 2022 | 36235542 | PubTator, text mining | PubMed |
| Adenosine, Schizophrenia and Cancer: Does the Purinergic System Offer a Pathway to Treatment? | Int J Mol Sci | 2022 | 36233136 | PubTator, text mining | PubMed |
| New Oxazolo[5,4-d]pyrimidines as Potential Anticancer Agents: Their Design, Synthesis, and In Vitro Biological Activity Research. | Int J Mol Sci | 2022 | 36232997 | PubTator, text mining | PubMed |
| The impaired distribution of adenosine deaminase isoenzymes in multiple sclerosis plasma and cerebrospinal fluid. | Front Mol Neurosci | 2022 | 36204140 | PubTator, text mining | PubMed |
| Adenosine signaling: Optimal target for gastric cancer immunotherapy. | Front Immunol | 2022 | 36189223 | PubTator, text mining | PubMed |
| Current Review in Basic Science: Animal Models of Focal Cortical Dysplasia and Epilepsy. | Epilepsy Curr | 2022 | 36187145 | PubTator, text mining | PubMed |
| A tumor association to be aware: endometrial cancer and colon cancer in relation to Lynch syndrome. | BJR Case Rep | 2022 | 36177269 | PubTator, text mining | PubMed |
Detection of BRCA1/2 pathogenic variants in patients with breast and/or ovarian cancer and their families. Analysis of 3,458 cases from Lower Silesia (Poland) according to the diagnostic algorithm of the National Cancer Control Programme. | Front Genet | 2022 | 36171877 | PubTator, text mining | PubMed |
| COVID 19 Associated Mucormycosis: Preventable Risk Factors Leading to a Better Prognosis: A Case Series. | Indian J Otolaryngol Head Neck Surg | 2022 | 36160947 | PubTator, text mining | PubMed |
| Remdesivir in treating hospitalized patients with COVID-19: A renewed review of clinical trials. | Front Pharmacol | 2022 | 36160434 | PubTator, text mining | PubMed |
| Characterization of Transcriptional Responses to Genomovirus Infection of the White Mold Fungus, Sclerotinia sclerotiorum. | Viruses | 2022 | 36146699 | PubTator, text mining | PubMed |
| Potential epigenetic molecular regulatory networks in ocular neovascularization. | Front Genet | 2022 | 36118885 | PubTator, text mining | PubMed |
| Functional Drug Screening of Small Molecule Inhibitors of Epigenetic Modifiers in Refractory AML Patients. | Cancers (Basel) | 2022 | 36077629 | PubTator, text mining | PubMed |
| Precision Medicine: Determination of Ribavirin Urinary Metabolites in Relation to Drug Adverse Effects in HCV Patients. | Int J Mol Sci | 2022 | 36077436 | PubTator, text mining | PubMed |
| The Role of Adenosine and Its Degradation Enzymes - Adenosinedeaminase and Adenosinekinase in Pathogenesis of Vasovagal Syncope. | Eur J Intern Med | 2022 | 36075846 | PubTator, text mining | PubMed |
| Liquid biopsy in lung cancer management. | Rom J Morphol Embryol | 2022 | 36074665 | PubTator, text mining | PubMed |
| Functional importance of coacervation to convert calcium polyphosphate nanoparticles into the physiologically active state. | Mater Today Bio | 2022 | 36065353 | PubTator, text mining | PubMed |
| Fertility-Sparing Treatment for Early-Stage Cervical Cancer ≥ 2 cm: A Problem with a Thousand Nuances-A Systematic Review of Oncological Outcomes. | Ann Surg Oncol | 2022 | 36064991 | PubTator, text mining | PubMed |
| Impact of Liver Functions by Repurposed Drugs for COVID-19 Treatment. | J Clin Transl Hepatol | 2022 | 36062269 | PubTator, text mining | PubMed |
| Frustration and the Kinetic Repartitioning Mechanism of Substrate Inhibition in Enzyme Catalysis. | J Phys Chem B | 2022 | 36044985 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/132/papers?page=17